Mr. Speaker, Bill C-17 has the support of every party in this House. When passed, it would empower the Minister of Health to, among other things, order dangerous drugs off the market without delay and require reporting of serious adverse drug reactions.
This bill is, without exaggeration, a matter of life and death for Canadians who may suffer serious adverse drug reactions in the coming months. The minister has stated that she is open to amendments to further strengthen the bill.
Can the Parliamentary Secretary to the Prime Minister and for Intergovernmental Affairs please tell us why this legislation has not yet been referred to the health committee?